SLC2A4 and type 2 diabetes mellitus: We confirmed that increased GLUT4 translocation induced glucose uptake via LKB1-dependent AMPK activation in vitro and improved glucose tolerance by AMPK activation in skeletal muscle in vivo, these compounds may be attractive candidate drugs for treatment of type 2 diabetes.